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Abstract RANTES may be one of the chemoattractants
involved in stimulating eosinophils and macrophages to migrate
selectively into bovine dominant follicles and into developing
corpora lutea. We sequenced a 736 bp fragment of the bovine
RANTES mRNA encoding the complete protein and defined the
ovarian source of RANTES mRNA. As demonstrated by
competitive RT-PCR, follicle-derived macrophages showed a
100^1000 times higher RANTES mRNA level compared to
unpurified granulosa cells or follicle-derived fibroblasts. By
means of in situ hybridization, RANTES mRNA positive
macrophages were located in the former thecal layer of the
developing corpora lutea.
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1. Introduction
Leukocytes are attracted into the ovary and in£uence cycli-
cally changing structures [1^3]. Recently, we reported that the
eosinophils suddenly increase in number to roughly 90% of
the leukocytes in the bovine corpus luteum of early develop-
ment [4]. In sheep, the eosinophils are assumed to in£uence
the neovascularization of the corpus luteum [5]. Macrophages
appear to increase in number within the thecal layer of dom-
inant follicles [6] and to contribute to periovulatory events
such as dilation, permeability and the sprouting of microves-
sels, as well as to the degradation of the basal membrane [3,7].
There are only a few data available on the chemoattractants
by which the various leukocyte subpopulations are drawn into
speci¢c ovarian areas at a precisely de¢ned moment [8,9].
RANTES is a favorite candidate in the CC (L-) chemokine
family for selectively recruiting both eosinophils and macro-
phages [10^12]. It is produced by a variety of cell types and
can be induced in many tissues by speci¢c stimuli [13,14].
RANTES certainly plays a role in reproduction. The concen-
tration of leukocytes, and especially macrophages, also
changes dramatically in the uterine epithelium during the es-
trous cycle. The instillation of RANTES into the uterine lu-
men of macrophage-colony stimulating factor (M-CSF) nulli-
zygous mutant mice (csfmop/csfmop) resulted in a dramatically
increased number of macrophages [15].
We investigated whether RANTES is upregulated in the
bovine ovary around the periovulatory period in order to
attract eosinophils and/or macrophages. FSH, LH and
PGE2 are potential candidates for triggering RANTES secre-
tion, and they have been investigated in cultures of isolated
ovarian cells. Whereas granulosa cells and ¢broblasts are
easily obtained from the bovine ovary, the small number of
leukocytes separated from dominant follicles was insu⁄cient
for this purpose. Recently, we described an easy method of
accessing macrophage-like cells in the bovine ovary [16]. In
the present study, these macrophage-like cells have de¢nitely
been identi¢ed as true macrophages. We also determined the
bovine RANTES mRNA sequence, since it was not available
from data bases, and evaluated the RANTES mRNA expres-
sion and regulation in di¡erent cell types derived from dom-
inant follicles and additional ovarian tissues by semiquantita-
tive RT-PCR and in situ hybridization.
2. Materials and methods
2.1. Isolation of cells and cell cultures
Bovine ovaries with regressed corpora lutea were obtained from the
local abattoir immediately after the death of the animal and staged as
recently described [16]. Dominant follicles were punctured to release
granulosa cells containing a low number of leukocytes. These leuko-
cytes consisted mainly of macrophages. In order to obtain pure gran-
ulosa cells, the leukocytes were removed from the primary cell harvest
(also described as unpuri¢ed granulosa cells) by incubation with an
anti-bovine CD18 monoclonal antibody (VMDR, Pullman, WA,
USA) followed by goat anti-mouse IgG-coated M-450 Dynabeads
(DYNAL GmbH, Hamburg, Germany). The cells were cultured
with DMEM/Ham’s F12 (GIBCO BRL, Grand Island, NY, USA)
with 5% FCS (unpuri¢ed granulosa cell cultures accumulate macro-
phage-like cells after few days [16]). These cells were phenotyped by
£ow cytometry, using anti-bovine CD18, CD14, CD45 and MHC-
class II monoclonal antibodies (VMDR) followed by FITC-labeled
goat anti-mouse F(ab’)2 immunoglobulins. The macrophage-like cells
expressed all those antigens (data not shown) which are characteristic
for peripheral blood monocytes and tissue macrophages. The cells
were therefore classi¢ed as true macrophages. Fibroblasts were ob-
tained from dominant follicles by cultivating small pieces of the wall
in DMEM with 10% FCS. Immunocytological methods, using anti-
CD18 and anti-vimentin (DAKO, Hamburg, Germany) monoclonal
antibodies and detection of 3L-hydroxy-steroid dehydrogenase (3L-
HSD) activity [17], revealed that the ¢broblasts and puri¢ed granulosa
cells represented pure fractions. Puri¢ed granulosa cells were CD183,
vimentin and showed 3L-HSD activity, whereas the ¢broblasts ex-
pressed only vimentin (data not shown). 3U105 cells were seeded into
six-well plates for 24 h. The medium was replaced with OPTI-MEM
(GIBCO) for another 12 h to eliminate possible RANTES mRNA
upregulation by FCS. Following that, the cells were incubated with
OPTI-MEM, containing bovine FSH (100 ng/ml; Biogenesis, Poole,
UK), LH (100 ng/ml; Biogenesis), lipopolysaccharide E. coli 055:B5
(LPS; 100 ng/ml; Sigma), prostaglandin E2 (PGE2, 500 U/ml; Sigma)
and 10 ng/ml phorbol-myristate acetate (PMA, Sigma).
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2.2. RNA isolation, cDNA synthesis and cloning of bovine RANTES
mRNA
Total RNA was isolated using the QIAGEN total RNA isolation
kit (QIAGEN GmbH, Hilden, Germany). Genomic DNA was di-
gested with 0.02 U DNase/Wg RNA (Roche Molecular Biochemicals,
Mannheim, Germany). 5 Wg of RNA was employed to synthesize
cDNA, using a ¢rst-strand cDNA synthesis kit from Amersham Phar-
macia Biotech (Freiburg, Germany) in a reaction volume of 15 Wl. The
homologous RANTES primers (5P-aca ggt acc atg aag gtc tc-3P) and
(5P-ctc atc tcc aaa gag ttg atg-3P) were designed by comparing human
and guinea pig RANTES mRNA sequences [18]. With these primers,
we identi¢ed the predicted 279 bp fragment in bovine small-intestine
cDNA by RT-PCR. The bovine primers were designed on the basis of
the determined sequence. The BoRants1 primer (5P-ata tgc ctc gga cac
cac g-3P) and a d(T)18 primer (Amersham Pharmacia Biotech) were
used to amplify the 3P untranslated region of bovine RANTES
cDNA. The unknown 5P sequence of RANTES mRNA was ampli¢ed
by single-strand ligation to single-stranded cDNA as described by
Stappert et al. [19]. Brie£y, the technique is based on covalent linkage
of an anchor oligonucleotide (5P-P-gta gga att cgg gtt gta ggg agg tcg
aca ttg cc-3P) with T4 RNA ligase (MBI Fermentas GmbH, St. Leon-
Rot, Germany) to ¢rst-strand cDNA treated with RNase H (Roche
Molecular Biochemicals) and primed with the speci¢c primer BoR-
antr2 (5P-aag ttc agg ttc aag gcg tc-3P). The anchored cDNA was then
ampli¢ed by using an anchor-speci¢c primer (5P-ggc aat gtc gac ctc cct
aca ac-3P) and BoRantr2 for 20 cycles, followed by a nested PCR with
a second anchor primer (5P-ctc cct aca acc cga att cct ac-3P) and
BoRantr1 (5P-tcg cac cca ctt ctt ctc tg-3P). All fragments were cloned
into a pGEM-T vector (Promega Corporation, Mannheim, Germany).
The sequence was determined in both strands.
2.3. Semiquantitative competitive RT-PCR
To quantify bovine GAPDH and RANTES cDNA, a rapid one-
step method was introduced to synthesize internal homologous com-
petitors [20]. Ampli¢cation of bovine small intestine cDNA with the
Borants1 (5P-ata tgc ctc gga cac cac g-3P) and a hybrid primer (5P-aag
ttc agg ttc aag gcg tct cgc acc cac ttc ttc tct g-3P) resulted in a 191 bp
bovine RANTES competitor. In order to quantify bovine GAPDH
cDNA, a 476 bp GAPDH competitor was synthesized, using Bo-
Gapdhs1 (5P-tga agg gtg gcg cca aga gg) and a hybrid (5P-tgc cag
ccc cag cat cga agc ctg ctt cac cac ctt ctt g-3P) primer. The competitors
were prepared and stabilized at de¢ned concentrations in the PCR
tubes in accordance with the method of Ko«hler et al. [21].
Variations across di¡erent cDNA preparations were corrected. All
samples were ¢rst adjusted to contain equal-input GAPDH cDNA
concentrations in a semi-quantitative PCR, using BoGapdhs1 and
BoGapdhr1 (5P-tgc cag ccc cag cat cga ag-3P) [22]. We then estimated
RANTES cDNA in the adjusted samples. cDNA samples were ti-
trated in RT-PCR tubes containing known copies of the RANTES
competitor. Both the sample cDNA and the competitor were co-am-
pli¢ed, using the BoRants1 and BoRantr2 primers. With this ap-
proach, two products were generated. One was derived from the
cDNA (218 bp) and the other, 27 bp smaller in size, from the
RANTES competitor. Based on the length di¡erence, the sample
cDNA and competitor PCR products were resolved by gel electro-
phoresis. The sample cDNA and competitor were quanti¢ed by meas-
uring the intensity of ethidium £uorescence with a cooled CCD 8 bit
image sensor and the data analyzed by Phoretix 1 D plus software
(Phoretix International, Newcastle-upon-Tyne, UK). The target cop-
ies equation was used to determine the ratio of sample cDNA copies/
PCR to the number of competitor copies added, multiplied by the
quotient of the cDNA signal divided by the competitor signal. Each
25 Wl ampli¢cation reaction contained 2.5 Wl 10U concentrated PCR
bu¡er (15 mM MgCl2), 0.3 U Taq DNA polymerase (Roche Molec-
ular Biochemicals, Mannheim, Germany), 100 WM dNTPs, 0.1 WM of
each primer, 1 Wl sample cDNA and the stabilized competitor in
adjusted dilutions. The mRNA levels of cultures obtained from sep-
arate experiments (n = 4) were presented as mean þ S.E.M. The
Mann^Whitney test was used to determine the statistical signi¢cance
of the di¡erence between basal and stimulated cells.
2.4. In situ hybridization of cultured cells and luteal tissue
The 303 bp RANTES riboprobe was synthesized by RT-PCR using
the BoRants2 and BoRantr2 primers, cloned into the pGEM-T vec-
tor, and linearized. The digoxigenin (DIG)-labelled antisense and
sense strands were generated, using the DIG RNA-labelling kit
(SP6/T7, Roche Molecular Biochemicals). Cells on chamber slides
were ¢xed in 4% bu¡ered formaldehyde and permeated with 0.1%
Triton X-100 in PBS. The pieces of ovarian tissue were ¢xed in SER-
RA solution (12 parts 95% ethanol, 6 parts 35% formaldehyde and 1
part acetic acid) and embedded in para⁄n wax. The section process-
ing, hybridization (500 ng DIG-labelled riboprobe/ml), washing and
staining were carried out in accordance with the protocol described by
Braissant and Wahli [23].
3. Results
3.1. Cloning of bovine RANTES mRNA
RT-PCR from the bovine small intestine cDNA with ho-
mologous human RANTES primers resulted in a predicted
279 bp fragment which did not contain the start and stop
codons of the coding region. The missing 5P coding region
and a 54 bp fragment of the 5P untranslated region were
ampli¢ed by the single-strand ligation to single-stranded
cDNA technique. 3P rapid ampli¢cation of cDNA end (3P
race) produced the sequence up to the stop codon, and an
additional 409 bp fragment on the 3P untranslated region.
This region did not contain the poly-A tail, since the oligo-
dT primer seems to bind to a poly-A-rich region approxi-
mately 360 bp further down from the stop codon than the
whole human RANTES mRNA sequence. The nucleotide
and predicted amino acid sequences of the coding region of
the bovine RANTES cDNA are shown in Fig. 1. The partial
bovine RANTES mRNA sequence is 736 bp long (EMBL,
accession number AJ 007043) and contains a 276 bp open
reading frame that encodes a 91 amino acid protein. Compar-
ison at the amino acid level revealed 80.6%, 76.3%, 75.3% and
82.8% identity with the human, mouse, rat and guinea pig
RANTES amino acid sequences, respectively.
3.2. Semiquantitative RANTES cDNA determination
Tissue cDNA samples were prepared from various regions
of the ovary. Most segments, including the wall of dominant
follicles and developing corpora lutea, were positive for
Fig. 1. Nucleotide sequence and predicted amino acid sequence of
bovine RANTES. Primer sequences are underlined.
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RANTES mRNA (data not shown). In a ¢rst series of in vitro
experiments, unpuri¢ed granulosa cells and ¢broblasts were
stimulated for 6, 12, and 24 h. All further experiments were
carried out after 12 h, i.e. the maximum of RANTES mRNA
expression. Both cell types expressed RANTES mRNA
under basal conditions (all data: mean þ S.E.M.;U10321
mol RANTES cDNA/PCR; unpuri¢ed granulosa cells :
21.2 þ 5.8; ¢broblasts: 3.3 þ 0.6). PMA, which is known to
be a RANTES expression regulator and is used as a positive
control, signi¢cantly stimulated RANTES mRNA levels in
both cell types (unpuri¢ed granulosa cells : 70.2 þ 16.8, ¢bro-
blasts: 66.7 þ 24.7, P6 0.03). LH and FSH signi¢cantly in-
creased RANTES mRNA in unpuri¢ed granulosa cells (LH:
69.1 þ 12.1; FSH 104.5 þ 29.3, P6 0.03), but not in ¢broblasts
(Fig. 2). PGE2 had no signi¢cant e¡ect. Surprisingly, LPS
signi¢cantly stimulated RANTES mRNA expression in un-
puri¢ed granulosa cells to up to 20-fold (250 þ 88.8,
P = 0.05). The experiments were therefore repeated using
pure granulosa cells. The basal RANTES mRNA decreased
down to the detection limit. Furthermore, none of the stim-
ulating substances brought about any increase in RANTES
mRNA (data not shown). At the same time the follicle-de-
rived macrophages showed a basal RANTES mRNA level
100^500 times higher than that of unpuri¢ed granulosa cells
(5630 þ 940). The signi¢cant positive response after stimulat-
ing macrophages with LPS (11570 þ 860, P = 0.05) indicated
that the LPS-increased RANTES mRNA in unpuri¢ed gran-
ulosa cells was produced by macrophages, not by the granu-
losa cells alone. LH, FSH and PGE2 did not signi¢cantly
stimulate RANTES mRNA in the macrophages.
Fig. 2. Semiquantitative competitive RANTES RT-PCR on stimulated ovarian-derived cell types. The RANTES competitors (only shown at
10320 and 10319 mol/PCR) were coampli¢ed with the sample cDNA in the same PCR tube. Both PCR products were separated by gel electro-
phoresis and quanti¢ed. One out of three representative experiments is shown.
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3.3. In situ hybridization
In contrast to the cultured granulosa cells and ¢broblasts,
the macrophages strongly expressed RANTES mRNA (Fig.
3A). RANTES mRNA positive cells were located in the for-
mer thecal layer in the early stage of corpus luteum develop-
ment (Fig. 3B). The positive cells often accumulated in the
infoldings between the heavily gyrated former granulosa layer,
the same area where eosinophils are located. Furthermore,
RANTES mRNA positive cells were present in the connective
tissue capsule of the developing luteal body and adjacent to
blood vessels. Large regressing follicles contained few
RANTES positive cells. This explains the positive RANTES
mRNA RT-PCR found in various regions of the ovary.
4. Discussion
Although Karstro«m-Encrantz et al. [24] recently found
RANTES in human follicular £uid in concentrations between
50^400 pg/ml, they argued that the chemokine does not play a
role in leukocyte attraction into the ovary, because the serum
levels are more than 50 times higher. It is important to em-
phasize that neither plasma nor serum measurements re£ect
the actual circulating levels of RANTES, because they largely
result from an ex vivo release of the chemokine from the K-
granules of platelets during the processing of blood samples
[25]. What is more, in humans the dominating neutrophils [26]
are attracted by CXC- and not CC-chemokines [24,27].
Cloning and sequencing of RANTES mRNA were essential
in order to verify its expression in the bovine ovary around
the periovulatory period. RT-PCR demonstrated RANTES
mRNA especially in the follicle wall and in the corpus luteum.
For the detection of the signal source, we examined unpuri¢ed
granulosa cells from the follicle harvest and ¢broblasts de-
rived from the follicle wall. Following the appearance of a
hormone-dependent leukocyte in£ux during the periovulatory
period, we investigated the e¡ect of FSH and LH on the
expression of RANTES mRNA. Both hormones increased
RANTES mRNA in unpuri¢ed granulosa cells, but not in
¢broblasts, which are known to lack the hormone receptors.
PMA, used as a positive control, leads to a prolonged stim-
ulation of RANTES secretion in unpuri¢ed granulosa cells
and ¢broblasts. In contrast, PGE2 found to be upregulated
in the periovulatory period and acting on granulosa cells in an
autocrine fashion, did not stimulate RANTES mRNA.
Surprisingly, LPS treatment caused a signi¢cant RANTES
mRNA increase in unpuri¢ed granulosa cells, which do not
express LPS receptors [28]. We assume that cells other than
granulosa cells also take part in RANTES mRNA expression.
Indeed, pure granulosa cells pretreated with an anti-CD18
monoclonal antibody in order to remove the leukocytes did
not react. Among the leukocytes known to contribute to
RANTES mRNA expression, macrophages especially are po-
tential candidates. Since they are few in number in the aspi-
rated follicle cells, we obtained macrophages from follicle cell
cultures. These cells must have been true macrophages be-
cause they expressed (1) the leukocyte common antigen
CD45 and CD18, molecules which have been detected on
leukocytes only, (2) CD14, an antigen exclusively expressed
Fig. 3. In situ hybridization of RANTES mRNA in co-cultures of follicle-derived macrophages and granulosa cells (A: A1U320, A2U160;
scale bar 50 Wm) and a corpus luteum in early development (B: U40, scale bar 250 Wm). The macrophages strongly express RANTES mRNA
(C), whereas the granulosa cells lack a signal (A1,B1). Staining with an anti-CD14 monoclonal antibody (A2,B2).
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on the surface of monocytes and most tissue macrophages and
(3) MHC class II, which is typical for monocytes and macro-
phages under physiological conditions [29].
The ovarian macrophages showed a 100^1000 higher basal
RANTES mRNA expression than pure granulosa cells and
¢broblasts. Corresponding to our data showing an LPS-in-
duced increase of RANTES mRNA in the macrophages,
Shin et al. [30] recently described two LPS-responsive ele-
ments in the 5P £anking region of murine RANTES mRNA
from stimulated macrophages. Although LH-receptor positive
macrophages have been located adjacent to the oocyte in large
preantral follicles and among granulosa cells of medium-sized
antral follicles [31], LH had no RANTES mRNA upregulat-
ing e¡ect on macrophages in our study. The failure of a
RANTES mRNA increase to appear after LH or FSH treat-
ment indicates that interactions between leukocytes and gran-
ulosa cells mediate the FSH and LH stimulating e¡ect in
unpuri¢ed granulosa cells.
Our in vitro experiments were supported by in situ hybrid-
ization of the corpus luteum at the early stage of development.
Comparing the localization and morphology of RANTES
mRNA and CD14 cells in successive sections revealed
that macrophages are indeed RANTES mRNA producers.
However, a few RANTES mRNA positive cells were also
found in the thecal layer of intact or regressing antral follicles
and adjacent to blood vessels. The results may indicate that
(1) RANTES is also involved in further ovarian events and/or
(2) that it is not the only chemokine responsible for attracting
leukocytes into the ovary during the periovulatory period.
Arici et al. [32] showed that in humans the monocyte/macro-
phage migration towards and into the dominant follicle may
occur through the modulation of monocyte chemoattractant
protein-1 (MCP-1). This ¢nding re£ects a complex network
involving the selective and coordinated production of individ-
ual chemokines, and the expression of chemokine receptors to
attract selective leukocyte subpopulations into the ovary.
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